This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.86% per year. These returns cover a period from January 1, 1988 through February 2, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
zacks-consensus-estimate: Archive
Bath & Body Works (BBWI) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release
by Zacks Equity Research
Bath & Body Works (BBWI) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
BBWINegative Net Change
consensus-outlook earnings earnings-consensus earnings-esp earnings-estimates-revisions earnings-expectations earnings-preview stock-price-change zacks-consensus-estimate
Earnings Preview: Tourmaline Oil Corp. (TRMLF) Q4 Earnings Expected to Decline
by Zacks Equity Research
Tourmaline Oil Corp. (TRMLF) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
TRMLFNegative Net Change
consensus-outlook earnings earnings-consensus earnings-esp earnings-estimates-revisions earnings-expectations earnings-preview stock-price-change zacks-consensus-estimate
Wall Street Analysts Think Nektar (NKTR) Could Surge 89.8%: Read This Before Placing a Bet
by Zacks Equity Research
The mean of analysts' price targets for Nektar (NKTR) points to an 89.8% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
NKTRPositive Net Change
earnings-consensus earnings-estimates-revisions zacks-consensus-estimate
Wall Street Analysts Think TAL Education (TAL) Could Surge 44.62%: Read This Before Placing a Bet
by Zacks Equity Research
The average of price targets set by Wall Street analysts indicates a potential upside of 44.6% in TAL Education (TAL). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
TALNegative Net Change
earnings-consensus earnings-estimates-revisions zacks-consensus-estimate
Wall Street Analysts Believe Avita Medical (RCEL) Could Rally 29.87%: Here's is How to Trade
by Zacks Equity Research
The consensus price target hints at a 29.9% upside potential for Avita Medical (RCEL). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
RCELNegative Net Change
earnings-consensus earnings-estimates-revisions zacks-consensus-estimate
Universal Insurance Holdings (UVE) Q4 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Universal Insurance (UVE) delivered earnings and revenue surprises of +66.92% and +9.37%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
UVEPositive Net Change HCIPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
UFP Technologies (UFPT) Q4 Earnings Top Estimates
by Zacks Equity Research
UFP (UFPT) delivered earnings and revenue surprises of +7.81% and -1.08%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
UFPTNegative Net Change TMCIPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Tigo Energy, Inc. (TYGO) Reports Q4 Loss, Misses Revenue Estimates
by Zacks Equity Research
Tigo Energy, Inc. (TYGO) delivered earnings and revenue surprises of +18.26% and -0.32%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
TYGONegative Net Change FTCIPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Zeta Global Holdings (ZETA) Q4 Earnings and Revenues Top Estimates
by Zacks Equity Research
Zeta (ZETA) delivered earnings and revenue surprises of +23.51% and +3.73%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
ZETAPositive Net Change AIRSPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Carlyle Secured Lending, Inc. (CGBD) Q4 Earnings and Revenues Miss Estimates
by Zacks Equity Research
Carlyle Secured Lending (CGBD) delivered earnings and revenue surprises of -12.23% and -9.03%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
CGBDNegative Net Change SCMNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank